Peter Burema's Colleagues at NextPharma
Peter Burema's Contact Details
+44 20 3585 4120
NextPharma
Peter Burema's Company Details
Say yes to what's next! NextPharma, your CDMO partner for pharmaceutical development and manufacturing with fast, flexible and personalised solutions for worldwide markets. We are a leading European contract manufacturer in the pharmaceutical, nutraceutical, biotech and healthcare industries. For us, the most important step is always the next. Welcome to NextPharma! Because speed drives us, fills our working world with dynamism and allows us to grow. Our best recipe for joint success: space for passion. Because we are sure: Where excellent service inspires, passion is the best medicine. Our 2,300 European employees are located in our centres of excellence in Berlin, Bielefeld, Goettingen and Waltrop (Germany), Limay and Ploermel (France), Tampere (Finland), Edinburgh (UK) and Asker (Norway). NextPharma develops and produces a broad range of pharmaceutical dosage forms: • Solids (tablets, hard and soft capsules, powders, controlled-release pellets) • Non-sterile liquids (emulsions, suspensions, syrups, solutions) • Sterile liquids (ophthalmic and otic solutions and emulsions) • Semi-solids (creams, gels, ointments, suppositories) Special containment areas are available for: • Hormones (solid and semi-solid) • Narcotics (controlled substances) • Penicillin and Cephalosporin beta lactam antibiotics (solids and dry syrups) • Highly-potent compounds (soft gel and liquid-filled hard capsules) • Clinical trials services Career opportunities: Passion meets prospects! Joining NextPharma means taking the next step. A strong step forward. Because you will be adding prospects to your passion. With vision. Whether you are a school-leaver, an entry-level candidate, a specialist or an executive: the pharmaceutical, nutraceutical, biotech and healthcare industries are full of challenges and future potential. And it’s a future that we at NextPharma want to shape. Together with you! #speed #passion #service